287 related articles for article (PubMed ID: 23340313)
21. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
22. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
[TBL] [Abstract][Full Text] [Related]
23. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
24. Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.
Olave MC; Vargas-Zambrano JC; Celis AM; Castañeda E; González JM
Mycoses; 2017 Jul; 60(7):447-453. PubMed ID: 28338245
[TBL] [Abstract][Full Text] [Related]
25. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
26. Spatial Quantification of the Population Exposed to Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Europe: Estimating the Immunocompetent and HIV/AIDS Patients Under Risk.
Alaniz AJ; Carvajal JG; Carvajal MA; Cogliati M; Vergara PM
Risk Anal; 2020 Mar; 40(3):524-533. PubMed ID: 31578757
[TBL] [Abstract][Full Text] [Related]
27. Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts.
Angkasekwinai P; Sringkarin N; Supasorn O; Fungkrajai M; Wang YH; Chayakulkeeree M; Ngamskulrungroj P; Angkasekwinai N; Pattanapanyasat K
Infect Immun; 2014 Sep; 82(9):3880-90. PubMed ID: 24980974
[TBL] [Abstract][Full Text] [Related]
28. Melanin deposition in two
Chrissian C; Camacho E; Fu MS; Prados-Rosales R; Chatterjee S; Cordero RJB; Lodge JK; Casadevall A; Stark RE
J Biol Chem; 2020 Feb; 295(7):1815-1828. PubMed ID: 31896575
[No Abstract] [Full Text] [Related]
29. Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265.
Sorrell TC; Juillard PG; Djordjevic JT; Kaufman-Francis K; Dietmann A; Milonig A; Combes V; Grau GE
Microbes Infect; 2016 Jan; 18(1):57-67. PubMed ID: 26369713
[TBL] [Abstract][Full Text] [Related]
30. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.
Jain AV; Zhang Y; Fields WB; McNamara DA; Choe MY; Chen GH; Erb-Downward J; Osterholzer JJ; Toews GB; Huffnagle GB; Olszewski MA
Infect Immun; 2009 Dec; 77(12):5389-99. PubMed ID: 19752036
[TBL] [Abstract][Full Text] [Related]
31. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study.
Hurtado JC; Castillo P; Fernandes F; Navarro M; Lovane L; Casas I; Quintó L; Marco F; Jordao D; Ismail MR; Lorenzoni C; Martinez-Palhares AE; Ferreira L; Lacerda M; Monteiro W; Sanz A; Letang E; Marimon L; Jesri S; Cossa A; Mandomando I; Vila J; Bassat Q; Ordi J; Menéndez C; Carrilho C; Martínez MJ
Sci Rep; 2019 May; 9(1):7493. PubMed ID: 31097746
[TBL] [Abstract][Full Text] [Related]
32. The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii.
Torda A; Kumar RK; Jones PD
Pathology; 2001 Nov; 33(4):475-8. PubMed ID: 11827415
[TBL] [Abstract][Full Text] [Related]
33. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.
Szymczak WA; Davis MJ; Lundy SK; Dufaud C; Olszewski M; Pirofski LA
mBio; 2013 Jul; 4(4):. PubMed ID: 23820392
[TBL] [Abstract][Full Text] [Related]
34. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility testing of amphotericin B for Cryptococcus neoformans variety grubii AFLP1/VNI and Cryptococcus gattii AFLP6/VGII by CLSI and flow cytometry.
Morales BP; Trilles L; Bertho ÁL; Junior IN; de Oliveira Rde V; Wanke B; Lazéra Mdos S
Mycoses; 2015 May; 58(5):273-9. PubMed ID: 25756839
[TBL] [Abstract][Full Text] [Related]
36. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
Bastos RW; Carneiro HCS; Oliveira LVN; Rocha KM; Freitas GJC; Costa MC; Magalhães TFF; Carvalho VSD; Rocha CE; Ferreira GF; Paixão TA; Moyrand F; Janbon G; Santos DA
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109169
[No Abstract] [Full Text] [Related]
37. [Mechanism of Cryptococcus Meningoencephalitis].
Miyazato A
Med Mycol J; 2016; 57(1):J27-32. PubMed ID: 26936349
[TBL] [Abstract][Full Text] [Related]
38.
Goughenour K; Creech A; Xu J; He X; Hissong R; Giamberardino C; Tenor J; Toffaletti D; Perfect J; Olszewski M
Front Cell Infect Microbiol; 2024; 14():1392015. PubMed ID: 38841113
[TBL] [Abstract][Full Text] [Related]
39. Factors Influencing the Nitrogen-Source Dependent Flucytosine Resistance in Cryptococcus Species.
Yang DH; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
mBio; 2023 Feb; 14(1):e0345122. PubMed ID: 36656038
[TBL] [Abstract][Full Text] [Related]
40. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection.
Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ
mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
